Non-Invasive Fundus Retinal Detection Technology for Early Diagnosis of Parkinson's Disease
Trial
N/A
Recruiting
Nov. 23, 2025
Bullous pemphigoid and its association with neural diseases: A propensity matched retrospective study.
Research
Journal of the American Academy of Dermatology
Nov. 22, 2025
Metformin in Parkinson Disease
Trial
Phase 2
Recruiting
Nov. 20, 2025
Flexible-Dose Trial in Early Parkinson's Disease (PD)
Trial
Phase 3
Completed
Nov. 20, 2025
Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
Trial
N/A
Enrolling by invitation
Nov. 20, 2025
Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
Trial
N/A
Recruiting
Nov. 20, 2025
Cortical Stimulation to Treat Mood and Behavioral Symptoms in Parkinson's Disease Patients
Trial
N/A
Completed
Nov. 20, 2025
A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease
Trial
Phase 2
Active, not recruiting
Nov. 20, 2025
Factors influencing activity performance and participation in usual life situations among people with Parkinson's disease: a mixed methods study.
Research
Disability and rehabilitation
Nov. 20, 2025
Application of Thoracic Epidural SCS for Managing FOG in Patients With Advanced Parkinson's Disease
Trial
N/A
Recruiting
Nov. 19, 2025
tACS Modulates Speech and Cognitive Impairments in People With PD by Targeting the Medial Frontal Cortex
Trial
N/A
Completed
Nov. 19, 2025
Improving Prognostic Confidence in Neurodegenerative Diseases Causing Dementia Using Peripheral Biomarkers and Integrative Modeling
Trial
N/A
Recruiting
Nov. 19, 2025
Fixational Microsaccades in Patients With Parkinson Disease.
Research
Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society
Nov. 19, 2025
[18F]ACI-15916 PET in α-synucleinopathies
Trial
Early Phase 1
Recruiting
Nov. 18, 2025
Respiratory-gated Transcutaneous Auricular Vagus Nerve Stimulation for Improving Apathy in Parkinson's Disease
Trial
N/A
Recruiting
Nov. 18, 2025
Multidisciplinary Study of Novel NMDA Modulation for Neurodegenerative Disorder
Trial
Phase 2
Completed
Nov. 18, 2025
A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease
Trial
Phase 2
Completed
Nov. 18, 2025
Clozapine-related Immunodeficiency in Parkinsons Disease
Trial
Phase 4
Recruiting
Nov. 18, 2025
Dual-target, High-dose TMS for PD Patients With FOG
Trial
N/A
Terminated
Nov. 18, 2025
6 Month Follow up Study on the Changes of Postural Stability in Parkinsonian Patients in Response to High Frequency TMS.
Trial
N/A
Recruiting
Nov. 18, 2025